News

The Latest

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

By Tim Murphy

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

By Tim Murphy

HIV Activist Jumps Into the Philadelphia City Council Race

Housing and displacement are a major focus of their campaign.

By Kenyon Farrow

Daniel Franzese Advocates for the HIV Community in Hollywood and the Halls of Congress

The actor and comedian speaks on his work at the AIDSWatch 2019 advocacy event -- and about playing an HIV-positive character.

By Charles Sanchez

In a Climate of Fear, HIV Services for Latinx Women Give Strength to Immigrant Communities

"If you educate yourself, you can protect yourself," says Thelma Garcia, the HIV service director of East Los Angeles Women's Center. "Helping different women in my community is the passion that keeps me going."

By Giuliani Alvarenga

New York City Faces Challenge to HIV/AIDS Progress With Proposed $59 Million in Cuts From Governor Cuomo

Five years after Andrew Cuomo announced his plan to end New York state's HIV epidemic by 2020, the governor is shutting off funds to vital HIV prevention and public health programs in New York City.

By Tim Murphy

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

By Tim Murphy

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

By Charles Sanchez

Archive Remembers Heroes and History of Black HIV/AIDS Activism

Through his historical research, Dan Royles has found a vibrant legacy of black AIDS activism going back to the beginning of the epidemic.

By George Kevin Jordan